Jan Westin

13.4k total citations · 1 hit paper
108 papers, 5.2k citations indexed

About

Jan Westin is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Jan Westin has authored 108 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Hematology, 34 papers in Genetics and 33 papers in Molecular Biology. Recurrent topics in Jan Westin's work include Multiple Myeloma Research and Treatments (45 papers), Cancer Treatment and Pharmacology (21 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers). Jan Westin is often cited by papers focused on Multiple Myeloma Research and Treatments (45 papers), Cancer Treatment and Pharmacology (21 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers). Jan Westin collaborates with scholars based in Sweden, Denmark and Norway. Jan Westin's co-authors include Martin Hjorth, Ingemar Turesson, Birgitta Swolin, Aleksander Weinfeld, Erik Holmberg, Mario Boccadoro, Brian G.M. Durie, Kazuyuki Shimizu, Robert A. Kyle and Joan Bladé and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jan Westin

106 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Staging System for Multiple Myeloma

2005 1.9k citations Ingemar Turesson, Jan Westin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Westin Sweden	34	4.0k	2.4k	2.0k	1.1k	342	108	5.2k
Atsushi Kuramoto Japan	29	2.0k 0.5×	1.6k 0.7×	1.4k 0.7×	763 0.7×	285 0.8×	157	4.7k
François Dreyfus France	42	4.0k 1.0×	3.0k 1.2×	1.0k 0.5×	1.6k 1.4×	107 0.3×	126	6.2k
Ilse Schwarzinger Austria	36	1.8k 0.4×	1.2k 0.5×	840 0.4×	914 0.8×	267 0.8×	136	4.0k
Bertrand Arnulf France	37	2.3k 0.6×	2.4k 1.0×	1.6k 0.8×	763 0.7×	126 0.4×	167	4.8k
Keisuke Toyama Japan	29	4.6k 1.1×	2.4k 1.0×	683 0.3×	1.8k 1.6×	175 0.5×	157	6.8k
E Archimbaud France	34	3.3k 0.8×	2.3k 1.0×	1.4k 0.7×	616 0.5×	63 0.2×	124	5.1k
L Degos France	43	3.6k 0.9×	3.4k 1.4×	907 0.4×	681 0.6×	192 0.6×	193	6.9k
B. Grosbois France	26	1.2k 0.3×	1.3k 0.5×	636 0.3×	780 0.7×	275 0.8×	118	2.6k
Joseph O. Moore United States	42	3.3k 0.8×	1.8k 0.7×	1.9k 0.9×	1.5k 1.3×	246 0.7×	148	6.6k
Lee‐Yung Shih Taiwan	30	1.7k 0.4×	1.2k 0.5×	663 0.3×	776 0.7×	525 1.5×	195	3.6k

Countries citing papers authored by Jan Westin

Since Specialization

Citations

This map shows the geographic impact of Jan Westin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Westin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Westin more than expected).

Fields of papers citing papers by Jan Westin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Westin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Westin. The network helps show where Jan Westin may publish in the future.

Co-authorship network of co-authors of Jan Westin

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Westin. A scholar is included among the top collaborators of Jan Westin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Westin. Jan Westin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Westin, Jan, et al.. (2024). DIGITISING SENSITIVE HERITAGE MONUMENTS IN ANTARCTICA. SHILAP Revista de lepidopterología. XLVIII-2/W4-2024. 461–467.

Lionel, Anath C., Penny Fang, Sairah Ahmed, et al.. (2024). Bridging Radiotherapy prior to Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 120(2). e622–e623.

Blimark, Cecilie, Ljupco Veskovski, Jan Westin, et al.. (2011). Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation. European Journal Of Haematology. 87(2). 117–122. 12 indexed citations

Palmblad, Jan, Magnus Björkholm, Jack Kutti, et al.. (2008). TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders. International Journal of Medical Sciences. 5(2). 87–91. 6 indexed citations

Andréasson, Björn, Eva Löfvenberg, & Jan Westin. (2005). Management of patients with polycythaemia vera: results of a survey among Swedish haematologists. European Journal Of Haematology. 74(6). 489–495. 19 indexed citations

Waage, Anders, Peter Gimsing, Gunnar Juliusson, et al.. (2004). Early response predicts thalidomide efficiency in patients with advanced multiple myeloma*. British Journal of Haematology. 125(2). 149–155. 29 indexed citations

Nilsson, Thérèse, Stig Lenhoff, Ingela Turesson, et al.. (2002). Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation. European Journal Of Haematology. 68(6). 345–353. 15 indexed citations

Thunberg, Ulf, Mats Bengtsson, Carsten Geisler, et al.. (1999). Linear reduction of clonal cells in stem cell enriched grafts in transplanted multiple myeloma. British Journal of Haematology. 104(3). 546–552. 11 indexed citations

Thunberg, Ulf, Britt Thuresson, Jan Westin, et al.. (1997). Presence of clonal cells in all stem cell enriched grafts in transplanted multiple myeloma.. Blood. 90. 218. 1 indexed citations

10.

Hjorth, Martin, Erik Holmberg, Stig Rödjer, Adam Taube, & Jan Westin. (1995). Patient accrual and quality of participation in a multicentre study on myeloma: a comparison between major and minor participating centres. British Journal of Haematology. 91(1). 109–115. 14 indexed citations

11.

Knudsen, Lene Meldgaard, Erik Hippe, Martin Hjorth, Erik Holmberg, & Jan Westin. (1994). Renal function in newly diagnosed multiple myeloma — A demographic study of 1353 patients. European Journal Of Haematology. 53(4). 207–212. 186 indexed citations

12.

Weinfeld, Aleksander, Birgitta Swolin, & Jan Westin. (1994). Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: Prospective study of efficacy and leukaemogenicity with therapeutic implications. European Journal Of Haematology. 52(3). 134–139. 137 indexed citations

13.

Jagenburg, R, et al.. (1993). Serum deoxythymidine kinase: no help in the diagnosis and prognosis of monoclonal gammopathy. British Journal of Haematology. 84(4). 746–748. 4 indexed citations

14.

Westin, Jan. (1991). Interferon therapy during the plateau phase of multiple myeloma: an update of a Swedish multicenter study.. PubMed. 18(5 Suppl 7). 37–40. 19 indexed citations

15.

Westin, Jan, Hans Carl Hasselbalch, Erik Hippe, et al.. (1991). Demonstrated Benefit of Continuous Interferon-Alpha-2b Therapy in Hairy Cell Leukemia. A Two-Year Follow-Up. Leukemia & lymphoma. 5(1). 23–31. 5 indexed citations

16.

Hjorth, Martin, et al.. (1990). Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan‐prednisone. British Journal of Haematology. 74(2). 185–191. 40 indexed citations

17.

Rödjer, Stig, Olle Vikrot, Anders Wåhlin, & Jan Westin. (1990). Effect of interferon alpha‐2b in advanced multiple myeloma. Journal of Internal Medicine. 227(1). 45–48. 4 indexed citations

18.

Swolin, Birgitta, Stig Rödjer, & Jan Westin. (1990). Bone marrow in vitro growth and cytogenetic studies in patients with fab‐classified primary myelodysplastic syndromes. American Journal of Hematology. 34(3). 175–180. 11 indexed citations

19.

Nilsson‐Ehle, Herman, et al.. (1989). Low serum cobalamin levels in a population study of 70- and 75-year-old subjects. Digestive Diseases and Sciences. 34(5). 716–723. 61 indexed citations

20.

Hasselbalch, Hans Carl, Ida Maria Lisse, Birgitta Swolin, et al.. (1988). Recombinant interferon‐alpha‐2b treatment of hairy‐cell leukaemia: Experience with a low‐dose schedule. European Journal Of Haematology. 41(5). 438–444. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact